--- title: "15:21 ET$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger--ACA, CRNX, LEG, and LPSN" type: "News" locale: "en" url: "https://longbridge.com/en/news/294728902.md" description: "Monteverde & Associates PC is investigating potential class action lawsuits regarding four mergers: Arcosa's sale to CRH Americas, Crinetics' sale to Vertex Pharmaceuticals, Leggett & Platt's sale to Somnigroup International, and LivePerson's sale to SoundHound AI. The firm urges shareholders of these companies to review the proposed transactions and shareholder vote dates." datetime: "2026-08-03T19:21:43.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/294728902.md) - [en](https://longbridge.com/en/news/294728902.md) - [zh-HK](https://longbridge.com/zh-HK/news/294728902.md) generator: "portal-rs" --- # 15:21 ET$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger--ACA, CRNX, LEG, and LPSN , /PRNewswire/ -- **Class Action Attorney** Juan Monteverde **with** Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a **Top 50 Firm** in the 2025 ISS Securities Class Action Services Report. We are headquartered at the **Empire State Building** in New York City and are investigating - **Arcosa, Inc. (NYSE: ACA)** related to its sale to CRH Americas, Inc. Under the terms of the proposed transaction, Arcosa shareholders are expected to receive $150.00 per share in cash. **ACT NOW. The Shareholder Vote is scheduled for September 4, 2026.** **Click here for more info** **https://monteverdelaw.com/case/arcosa-inc/.** **It is free and there is no cost or obligation to you.** - **Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX)** related to its sale to Vertex Pharmaceuticals Incorporated. Under the terms of the proposed transaction, Crinetics shareholders are expected to receive $85.00 per share in cash. **ACT NOW. The Shareholder Vote is scheduled for August 28, 2026.** **Click here for more information https://monteverdelaw.com/case/crinetics-pharmaceuticals-inc/. It is free and there is no cost or obligation to you.** - **Leggett & Platt, Incorporated (NYSE: LEG)** related to its sale to Somnigroup International Inc. Under the terms of the proposed transaction, Leggett & Platt shareholders will receive 0.1455 shares of Somnigroup common stock for each share of Leggett & Platt common stock. **ACT NOW. The Shareholder Vote is scheduled for August 20, 2026.** **Click here for more information https://monteverdelaw.com/case/leggett-platt-incorporated/. It is free and there is no cost or obligation to you.** - **LivePerson, Inc. (NASDAQ: LPSN)** related to its sale to SoundHound AI, Inc. for an equity value of $43 million. **ACT NOW. The Shareholder Vote is scheduled for August 20, 2026.** **Click here for more info** **https://monteverdelaw.com/case/liveperson-inc/.** **It is free and there is no cost or obligation to you.** **NOT ALL LAW FIRMS ARE THE SAME.** Before you hire a law firm, you should talk to a lawyer and ask: 1. Do you file class actions and go to Court? 2. When was the last time you recovered money for shareholders? 3. What cases did you recover money in and how much? **About Monteverde & Associates PC** Our firm litigates and has recovered money for shareholders…and we do it from our offices in the Empire State Building. We are a national class action securities firm with a successful track record in trial and appellate courts, including the U.S. Supreme Court. **No company, director or officer is above the law.** If you own common stock in the above listed company and have concerns or wish to obtain additional information free of charge, please visit our **website** or contact Juan Monteverde, Esq. either via e-mail at **\[email protected\]** or by telephone at (212) 971-1341. Contact: Juan Monteverde, Esq. MONTEVERDE & ASSOCIATES PC **The Empire State Building** 350 Fifth Ave. Suite 4740 New York, NY 10118 United States of America \[email protected\] Tel: (212) 971-1341 Attorney Advertising. (C) 2026 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter. SOURCE Monteverde & Associates PC ### Related Stocks - [CRNX.US](https://longbridge.com/en/quote/CRNX.US.md) - [LEG.US](https://longbridge.com/en/quote/LEG.US.md) - [LPSN.US](https://longbridge.com/en/quote/LPSN.US.md) - [ACA.US](https://longbridge.com/en/quote/ACA.US.md) - [SGI.US](https://longbridge.com/en/quote/SGI.US.md) - [CRH.US](https://longbridge.com/en/quote/CRH.US.md) - [SOUN.US](https://longbridge.com/en/quote/SOUN.US.md) - [VRTX.US](https://longbridge.com/en/quote/VRTX.US.md) - [SOUX.US](https://longbridge.com/en/quote/SOUX.US.md) - [SOUNW.US](https://longbridge.com/en/quote/SOUNW.US.md) ## Related News & Research - [LPSN: Adjournment was approved to reconvene on September 2nd after insufficient votes for the merger](https://longbridge.com/en/news/296507504.md) - [Crinetics supplements proxy disclosures for Vertex USD 85-per-share buyout after shareholder suits](https://longbridge.com/en/news/296395094.md) - [Are Wall Street Analysts Bullish on Vertex Stock?](https://longbridge.com/en/news/296449653.md) - [Callan Family Office LLC Buys New Position in Vertex Pharmaceuticals Incorporated $VRTX](https://longbridge.com/en/news/296677120.md) - [The Bull Case For Vertex (VRTX) Could Change Following Upgraded 2026 Guidance And Pipeline Momentum - Learn Why](https://longbridge.com/en/news/296583461.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**